Compare · KRMD vs SACH
KRMD vs SACH
Side-by-side comparison of KORU Medical Systems Inc. (KRMD) and Sachem Capital Corp. (SACH): market cap, price performance, sector, and recent activity on the wire.
Summary
- KRMD operates in Health Care, while SACH operates in Real Estate - the two are in different parts of the market.
- KRMD is the larger of the two at $139.9M, about 3.5x SACH ($39.9M).
- KRMD has been more active in the news (6 items in the past 4 weeks vs 1 for SACH).
- KRMD has more recent analyst coverage (6 ratings vs 5 for SACH).
- Company
- KORU Medical Systems Inc.
- Sachem Capital Corp.
- Price
- $3.01-0.33%
- $0.83+1.48%
- Market cap
- $139.9M
- $39.9M
- 1M return
- -
- -12.18%
- 1Y return
- -
- -22.02%
- Industry
- Medical/Dental Instruments
- Real Estate Investment Trusts
- Exchange
- NASDAQ
- AMEX
- IPO
- 2017
- News (4w)
- 6
- 1
- Recent ratings
- 6
- 5
KORU Medical Systems Inc.
Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
Sachem Capital Corp.
Sachem Capital Corp. operates as a real estate finance company. The company is involved in the originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located primarily in Connecticut. It offers loans to real estate investors to fund their acquisition, renovation, rehabilitation, development, and/or improvement of residential or commercial properties. The company has elected to be taxed as a real estate investment trust (REIT) and would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. Sachem Capital Corp. was founded in 2010 and is based in Branford, Connecticut.
Latest KRMD
- Director Manko Joseph M. Jr. was granted 5,119 shares (SEC Form 4)
- Director Wholihan Edward was granted 5,119 shares, increasing direct ownership by 10% to 56,431 units (SEC Form 4)
- Director French Donna was granted 5,119 shares, increasing direct ownership by 5% to 103,633 units (SEC Form 4)
- Director Cascella Robert was granted 5,119 shares, increasing direct ownership by 5% to 103,274 units (SEC Form 4)
- Chairman of the Board Fletcher R John was granted 7,679 shares, increasing direct ownership by 3% to 239,836 units (SEC Form 4)
- Director Matin Shahriar was granted 5,119 shares, increasing direct ownership by 5% to 106,263 units (SEC Form 4)
- Chief Commercial Officer Kalbermatten Adam R bought $101,120 worth of shares (32,000 units at $3.16), increasing direct ownership by 9% to 394,017 units (SEC Form 4)
- Chief Commercial Officer Kalbermatten Adam R converted options into 75,000 shares and covered exercise/tax liability with 25,483 shares, increasing direct ownership by 16% to 362,017 units (SEC Form 4) to satisfy withholding obligation
- SEC Form 10-Q filed by KORU Medical Systems Inc.
- KORU Medical Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Latest SACH
- After Seeing Tremendous Opportunity Across Its Existing Markets, A4 Capital Partners Is Launching An East Coast Expansion Initiative, With Plans To Enter Select Mountain West Markets.
- SEC Form DEF 14A filed by Sachem Capital Corp.
- Sachem Capital Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Sachem Capital Corp. Announces Common and Preferred Dividends
- Sachem Capital Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form DEFA14A filed by Sachem Capital Corp.
- Sachem Capital Reports Second Quarter 2026 Results
- SEC Form 10-Q filed by Sachem Capital Corp.
- Sachem Capital Sets Date for Second Quarter 2026 Earnings Release and Pending Asset Contribution Transaction Update
- Sachem Capital Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits